HomeNXGN • TLV
add
Nextgen Biomed Ltd
Previous close
ILA 48.70
Year range
ILA 45.60 - ILA 86.00
Market cap
7.21M ILS
Avg Volume
58.75K
P/E ratio
-
Dividend yield
-
Primary exchange
TLV
Market news
Financials
Income Statement
Revenue
Net income
| (ILS) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.60M | 2.01% |
Net income | -1.59M | 73.72% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.56M | 0.10% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (ILS) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 35.00K | -46.15% |
Total assets | 575.00K | 120.31% |
Total liabilities | 3.04M | 145.16% |
Total equity | -2.46M | — |
Shares outstanding | 10.90M | — |
Price to book | -2.32 | — |
Return on assets | -693.48% | — |
Return on capital | 177.78% | — |
Cash Flow
Net change in cash
| (ILS) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.59M | 73.72% |
Cash from operations | -565.00K | 43.89% |
Cash from investing | -12.50K | 90.42% |
Cash from financing | 493.00K | — |
Net change in cash | -88.50K | 92.23% |
Free cash flow | -472.69K | 8.16% |
About
Founded
1990
Website
Employees
3
